Laval, Que. — Labopharm Inc. is cutting 35 jobs, about one quarter of its work force.
The drug developer widened its third-quarter loss to $6.9-million or 12 cents a share versus a loss of $6-million or 11 cents in the corresponding period last year.
Revenue contracted to $6.6-million from $9.4-million.